Why ImmunoTherapeutics (BTX) Stock Soared 210% Last Week?

At the start of a new trading week, investors are often known to look into stocks that had clocked considerably a week in the previous week and by that token, it would be a good idea to look into the ImmunoTherapeutics Inc (NYSEAMERICAN:BTX) stock.

Last week, the Brooklyn stock emerged as one of the biggest gainers and managed to clock gains of as much as 210 through its course. The stock attracted the interest of plenty of retail investors last week.

Related:  Bethesda's long term growing stock to get 2x returns: Northwest Biotherapeutics (NWBO)

However, that is not all. It seems that the Brooklyn stock is also a target of retail investors from the Reddit group WallStreetBets. The WallStreetBets members seem to have noticed the short interest in the stock and its low float in order to mount a campaign.

Hence, it is no surprise that the stock managed to record such gains last week. It now remains to be seen if it can continue to record such gains in the coming week.

Richard McEntire

Finance and Entertainment Reporter Richard is a bottle of wine - the older the sweeter. He has already found the sweetest hobby in writing entertainment and finance news for Own Snap. Readers get the updated posts regularly from him searching for real-time news.